YOLFTbeta
Hubei Jumpcan Pharmaceutical Co Ltd

Hubei Jumpcan Pharmaceutical Co Ltd

600566 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

30.00CNY+0.13 (+0.44%)

Price History

Full chart

Market Stats

Previous Close29.87
Open29.65
Day Range29.51 – 30.36
52-Week Range21.13 – 29.60
Volume8.62M
Market Cap23.62B
P/E (TTM)12.81
Forward P/E0.00
EPS2.00
Dividend Yield6.79%
Beta0.07
50-Day Avg25.54
200-Day Avg26.36

About

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicines in China. The company offers drugs in the fields of pediatrics, respiratory system, digestive system, and gynecology. It is also involved in daily chemical product sales; and wholesale and retail pharmaceuticals. The company is headquartered in Taixing, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Fei Cao
  • Employees4.14K
  • HeadquartersBaotawan, Taixing, China, 225441, China
  • Websitehttps://www.jumpcan.com

Leadership

  • Mr. Fei CaoVice Chairman & GM · b. 1983
  • Mr. Hong Quan YanDeputy GM & Financial Director · b. 1968
  • Mr. Wen Zheng ShiDirector of Human Resources · b. 1979
  • Mr. Wei CaoDeputy GM, Board Secretary & Director · b. 1987
  • Mr. Qu Rong HuangEmployee Representative Director · b. 1962
  • Jian Hong XiAccounting Supervisor

Financials

Income Statement

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue65.07M81.94M97.82M113.96M107.29M113.43M146.14M176.16M200.72M218.55M212.99M222.02M237.14M240.47M1.92B2.45B2.99B3.77B4.68B5.64B7.21B6.94B6.16B7.63B9.00B9.65B8.02B6.22B
Growth (%)-+25.93%+19.37%+16.50%-5.85%+5.72%+28.84%+20.54%+13.94%+8.89%-2.55%+4.24%+6.81%+1.40%+698.49%+27.47%+22.02%+26.17%+24.15%+20.61%+27.76%-3.72%-11.17%+23.77%+17.90%+7.32%-16.96%-22.43%
Cost of Revenue43.47M51.62M67.61M81.61M75.91M85.91M104.34M126.71M138.05M160.74M154.70M157.89M169.77M166.98M314.65M369.70M468.94M590.03M690.45M849.03M1.10B1.11B1.13B1.28B1.54B1.78B1.67B1.31B
Gross Profit21.60M30.32M30.21M32.35M31.39M27.52M41.80M49.45M62.67M57.81M58.29M64.13M67.37M73.49M1.61B2.08B2.52B3.18B3.99B4.79B6.11B5.83B5.03B6.35B7.46B7.87B6.35B4.91B
Gross Margin33.20%37.00%30.88%28.38%29.25%24.26%28.60%28.07%31.22%26.45%27.37%28.88%28.41%30.56%83.61%84.90%84.30%84.34%85.24%84.95%84.79%84.00%81.67%83.27%82.91%81.52%79.21%78.95%
Operating Expense9.50M10.67M10.26M11.46M12.27M16.96M25.64M29.83M48.91M47.33M38.17M46.43M59.99M68.71M1.35B1.66B1.95B2.42B2.93B3.42B4.21B3.97B3.57B4.42B5.04B4.61B3.49B3.03B
Operating Income12.10M19.65M19.94M20.88M19.11M10.56M16.17M19.62M13.76M10.47M20.11M17.70M7.38M4.78M252.75M414.59M564.48M755.62M1.06B1.37B1.90B1.86B1.47B1.93B2.42B3.26B2.86B1.88B
Operating Margin18.59%23.98%20.39%18.32%17.81%9.31%11.06%11.14%6.86%4.79%9.44%7.97%3.11%1.99%13.16%16.94%18.90%20.05%22.60%24.26%26.38%26.77%23.83%25.33%26.94%33.75%35.71%30.19%
EBITDA9.01M15.81M30.84M29.70M33.02M24.80M29.36M34.05M38.80M43.16M37.76M37.05M41.30M46.02M299.66M486.00M632.37M847.35M1.16B1.50B2.04B2.04B1.67B1.96B2.56B3.18B2.73B2.48B
EBITDA Margin13.85%19.30%31.53%26.06%30.77%21.86%20.09%19.33%19.33%19.75%17.73%16.69%17.41%19.14%15.61%19.86%21.18%22.49%24.72%26.60%28.33%29.32%27.03%25.73%28.47%32.99%34.01%39.95%
Net Income10.63M17.02M14.55M17.70M13.89M7.40M7.43M8.43M9.73M10.88M8.38M7.71M8.46M7.92M237.67M402.72M519.39M686.57M934.18M1.22B1.69B1.62B1.28B1.72B2.17B2.82B2.53B1.78B
Net Income Margin16.33%20.77%14.87%15.53%12.95%6.53%5.08%4.79%4.85%4.98%3.93%3.47%3.57%3.29%12.38%16.45%17.39%18.22%19.97%21.68%23.42%23.39%20.72%22.53%24.13%29.24%31.58%28.59%
R&D------------2.37M8.37M82.14M90.91M110.25M127.12M145.30M165.66M196.48M210.14M243.75M523.44M553.30M464.40M462.03M385.10M
R&D as % of Total Revenue------------1.00%3.48%4.28%3.71%3.69%3.37%3.11%2.94%2.73%3.03%3.95%6.86%6.15%4.81%5.76%6.19%
Interest Expense1.56M1.45M1.81M1.75M2.87M3.43M7.55M9.05M10.31M9.36M10.35M11.57M11.95M10.92M13.25M13.68M4.27M2.45M401.76K5.96M34.67M31.17M33.59M35.48M31.24M17.58M27.27M11.45M
Interest Expense % of Total Revenue2.40%1.77%1.85%1.53%2.67%3.03%5.17%5.14%5.13%4.28%4.86%5.21%5.04%4.54%0.69%0.56%0.14%0.07%0.01%0.11%0.48%0.45%0.54%0.46%0.35%0.18%0.34%0.18%

Balance Sheet

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets186.23M196.69M223.38M582.65M607.22M650.39M697.90M732.21M786.51M802.32M829.61M836.22M863.16M961.82M992.87M2.01B3.36B3.59B4.99B6.66B7.80B8.66B10.52B12.13B14.98B18.14B18.46B17.70B
Total Liabilities77.79M71.23M83.37M133.08M148.17M183.92M223.98M251.96M300.69M303.49M323.43M323.37M342.89M435.00M502.07M862.04M1.06B872.59M1.30B2.26B2.34B2.56B2.75B3.00B3.63B4.77B3.73B3.07B
Total Equity108.44M125.46M140.01M449.57M458.15M465.55M472.98M479.29M484.84M497.82M505.14M511.78M519.18M525.72M489.68M1.15B2.29B2.67B3.66B4.40B5.46B6.10B7.76B9.12B11.34B13.35B14.70B14.61B
Cash10.16M5.14M11.35M280.53M111.32M136.77M91.18M75.94M60.15M81.70M83.44M83.54M64.13M62.87M57.11M65.05M645.06M270.46M890.32M951.61M1.59B2.28B2.96B3.82B4.82B7.74B6.67B5.44B
Total Debt28.92M32.52M36.64M89.74M107.47M133.67M163.67M155.10M196.50M196.00M195.50M210.42M214.92M285.22M307.52M260.00M280.00M71.31M84.93M697.87M552.64M576.81M603.82M630.12M400.65M1.04B788.19M-
Net Debt18.76M27.39M25.30M-190.79M-3.85M-3.10M72.49M79.16M136.35M114.30M112.06M126.88M150.79M222.35M250.41M194.95M-365.06M-199.15M-805.39M-253.74M-1.03B-1.71B-2.36B-3.19B-4.42B-6.16B-5.88B-

Cash Flow

Currency: CNY2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow23.73M7.43M22.00M2.24M-37.74M63.38M4.24M36.72M23.05M4.92M51.13M411.24K27.01M287.16M616.11M645.48M913.10M1.19B1.71B2.15B1.78B1.89B2.62B3.46B2.18B1.20B
Investing Cash Flow-19.81M-88.07M-201.22M-33.58M-31.57M-59.51M-51.81M-6.41M-7.53M-7.01M-74.89M-59.23M-44.41M-261.33M-649.80M-423.32M-394.43M-1.24B-263.15M-444.46M-1.48B-673.30M-1.50B-476.35M-2.04B-
Financing Cash Flow2.29M349.83M10.01M16.12M23.72M-19.10M31.78M-8.77M-13.78M2.19M4.35M57.55M8.53M11.32M612.87M-595.93M81.44M133.00M-810.71M-1.01B373.80M-361.19M-117.58M-150.69M-1.21B-
Capital Expenditure19.41M88.07M117.09M39.99M64.94M59.80M51.83M7.83M8.33M7.19M76.50M60.74M44.67M270.10M301.51M395.98M323.49M746.25M668.06M546.44M429.63M248.32M243.66M301.64M174.34M95.86M
Free Cash Flow4.31M-80.65M-95.09M-37.75M-102.68M3.58M-47.59M28.89M14.72M-2.27M-25.37M-60.33M-17.66M17.06M314.60M249.50M589.60M442.50M1.04B1.60B1.35B1.65B2.38B3.16B2.00B1.10B
Dividends Paid1.81M4.43M14.42M8.75M7.55M10.80M12.38M10.82M13.79M12.32M13.01M12.30M13.64M15.68M42.32M314.83M546.99M591.46M810.69M1.00B1.00B399.72M604.03M811.11M1.20B1.93B
FCF to OCF18.18%-1086.09%-432.17%-1682.56%272.09%5.64%-1121.72%78.66%63.85%-46.18%-49.62%-14669.18%-65.37%5.94%51.06%38.65%64.57%37.22%60.91%74.56%75.89%86.89%90.70%91.29%91.99%92.00%
Dividend Paid to FCF41.98%-5.50%-15.17%-23.18%-7.35%301.96%-26.02%37.46%93.67%-542.49%-51.28%-20.40%-77.22%91.88%13.45%126.19%92.77%133.66%77.87%62.60%74.14%24.28%25.41%25.65%59.73%174.94%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Oct 27, 2014Feb 15, 2015Apr 28, 2015Aug 16, 2015Oct 27, 2015Mar 6, 2016Apr 24, 2016Aug 9, 2016Oct 21, 2016Feb 6, 2017Apr 28, 2017Jul 27, 2017Oct 16, 2017Feb 28, 2018Apr 20, 2018Jul 27, 2018Oct 19, 2018Dec 31, 2018Apr 20, 2019Aug 23, 2019Oct 25, 2019Mar 12, 2020Apr 24, 2020Jul 22, 2020Oct 23, 2020Apr 16, 2021Aug 20, 2021Oct 29, 2021Apr 22, 2022Aug 19, 2022Oct 23, 2022Apr 17, 2023Aug 13, 2023
EPS Estimate-------------------------------------------------------
EPS Actual0.000.020.020.010.000.020.030.010.010.020.04-0.000.010.010.02-0.280.00-0.130.130.660.160.170.160.180.200.220.210.240.270.290.290.320.360.360.400.390.570.460.570.470.460.560.420.390.570.270.340.350.460.470.640.490.640.620.72
Surprise-------------------------------------------------------
Timing----------------------Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hours-Pre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap23.62B
Enterprise Value12.31B
Trailing P/E12.81
Forward P/E0.00
Price / Sales4.07
Price / Book1.64
EPS2.00
Book Value14.96
Revenue (TTM)5.80B
Gross Profit (TTM)4.68B
EBITDA2.15B
Profit Margin31.69%
Operating Margin25.34%
Return on Equity13.42%
Return on Assets6.86%
Shares Outstanding921.76M
Shares Float344.36M
Beta0.07
Dividend Yield6.79%
Dividend Rate1.74
Payout Ratio87.00%

Dividends

20231×
0.88Jul 3, 2023
20221×
0.68May 26, 2022
20211×
0.45May 26, 2021
20201×
1.23Apr 24, 2020
20191×
1.23Jun 3, 2019
20181×
1.00Jun 1, 2018
20171×
0.73Apr 28, 2017
20161×
0.70Apr 20, 2016
20151×
0.40Apr 7, 2015
20121×
0.01May 16, 2012
20111×
0.01Jul 12, 2011
20101×
0.01May 18, 2010
20091×
0.01May 27, 2009
20081×
0.01Jun 12, 2008
20071×
0.01May 28, 2007
20062×
0.02May 26, 20060.91Apr 12, 2006
20051×
0.02May 27, 2005
20031×
0.04May 29, 2003
20021×
0.08May 23, 2002

Stock Splits

  • May 18, 201013:10